Plasma lipids and cerebral small vessel disease

Neurology

Volumn 83, Issue 20, 2014, Pages 1844-1852

  Schilling, Sabrina ^a   Tzourio, Christophe ^a   Dufouil, Carole ^a   Zhu, Yicheng ^a,b   Berr, Claudine ^c,d   Alpérovitch, Annick ^a,e   Crivello, Fabrice ^f   Mazoyer, Bernard ^f   Debette, Stéphanie ^a,c,g,h,i,j  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^c INSERM   (France)

^d UNIV MONTPELLIER   (France)

^e SORBONNE UNIVERSITÉ   (France)

^f CNRS   (France)

^g LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^h HÔPITAL LARIBOISIÈRE   (France)

ⁱ BORDEAUX UNIVERSITY HOSPITAL   (France)

^j FRAMINGHAM HEART STUDY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; LIPID;

ARTICLE; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; COHORT ANALYSIS; HUMAN; LIPID BLOOD LEVEL; META ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RISK FACTOR; WHITE MATTER; AGED; BLOOD; CROSS-SECTIONAL STUDY; DIET RESTRICTION; FEMALE; HEALTH CARE PLANNING; MALE; META ANALYSIS (TOPIC); MIDDLE AGED; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CEREBRAL SMALL VESSEL DISEASES; COHORT STUDIES; COMMUNITY HEALTH PLANNING; CROSS-SECTIONAL STUDIES; FASTING; FEMALE; HUMANS; LIPIDS; MAGNETIC RESONANCE IMAGING; MALE; META-ANALYSIS AS TOPIC; MIDDLE AGED; RISK FACTORS;

EID: 84925286908     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000000980     Document Type: Article

References (40)

1. Kannel WB, Castelli WP, Gordon T, McNamara PM. Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham Study. Ann Intern Med 1971;74:1-12.
2. Lindenstrom E, Boysen G, Nyboe J. Influence of total cholesterol, high density lipoprotein cholesterol, and triglycerides on risk of cerebrovascular disease: The Copenhagen City Heart Study. BMJ 1994;309:11-15.
3. Cholesterol, diastolic blood pressure, and stroke: 13, 000 strokes in 450, 000 people in 45 prospective cohorts. Prospective studies collaboration. Lancet 1995;346: 1647-1653.
4. Woo D, Kissela BM, Khoury JC, et al. Hypercholesterolemia, HMG-CoA reductase inhibitors, and risk of intracerebral hemorrhage: A case-control study. Stroke 2004;35: 1360-1364.
5. Segal AZ, Chiu RI, Eggleston-Sexton PM, Beiser A, Greenberg SM. Low cholesterol as a risk factor for primary intracerebral hemorrhage: A case-control study. Neuroepidemiology 1999;18:185-193.
6. Greenberg SM. Small vessels, big problems. N Engl J Med 2006;354:1451-1453.
7. Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis: A review. Stroke 1997;28:652-659.
8. Debette S, Beiser A, DeCarli C, et al. Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: The Framingham Offspring Study. Stroke 2010; 41:600-606.
9. Khan U, Porteous L, Hassan A, Markus HS. Risk factor profile of cerebral small vessel disease and its subtypes. J Neurol Neurosurg Psychiatry 2007;78:702-706.
10. Jackson C, Sudlow C. Are lacunar strokes really different? A systematic review of differences in risk factor profiles between lacunar and nonlacunar infarcts. Stroke 2005; 36:891-901.
11. 3C Study Group. Vascular factors and risk of dementia: design of the Three-City Study and baseline characteristics of the study population. Neuroepidemiology 2003;22: 316-325.
12. Zureik M, Ducimetiere P, Touboul PJ, et al. Common carotid intima-media thickness predicts occurrence of carotid atherosclerotic plaques: longitudinal results from the Aging Vascular Study (EVA) study. Arterioscler Thromb Vasc Biol 2000;20:1622-1629.
13. Dufouil C, deKersaint-Gilly A, Besancon V, et al. Longitudinal study of blood pressure and white matter hyperintensities: The EVA MRI Cohort. Neurology 2001;56: 921-926.
14. Maillard P, Delcroix N, Crivello F, et al. An automated procedure for the assessment of white matter hyperintensities by multispectral (T1, T2, PD) MRI and an evaluation of its between-centre reproducibility based on two large community databases. Neuroradiology 2008;50: 31-42.
15. Soumare A, Elbaz A, Zhu Y, et al. White matter lesions volume and motor performances in the elderly. Ann Neurol 2009;65:706-715.
16. DeCarli C, Fletcher E, Ramey V, Harvey D, Jagust WJ. Anatomical mapping of white matter hyperintensities (WMH): exploring the relationships between periventricular WMH, deep WMH, and total WMH burden. Stroke 2005;36:50-55.
17. Zhu YC, Tzourio C, Soumare A, Mazoyer B, Dufouil C, Chabriat H. Severity of dilated Virchow-Robin spaces is associated with age, blood pressure, and MRI markers of small vessel disease: A population-based study. Stroke 2010;41:2483-2490.
18. Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013;12:822-838.
19. Satizabal CL, Zhu YC, Mazoyer B, Dufouil C, Tzourio C. Circulating IL-6 and CRP are associated with MRI findings in the elderly: The 3C-Dijon Study. Neurology 2012; 78:720-727.
20. Schilling S, DeStefano AL, Sachdev P, et al. APOE genotype and MRI-markers of cerebrovascular disease: A systematic review and meta-analysis. Neurology 2013;81: 292-300.
21. Fornage M, Debette S, Bis JC, et al. Genome-wide association studies of cerebral white matter lesion burden: The CHARGE Consortium. Ann Neurol 2011;69:928-939.
22. Park K, Yasuda N, Toyonaga S, et al. Significant association between leukoaraiosis and metabolic syndrome in healthy subjects. Neurology 2007;69:974-978.
23. Carmelli D, Swan GE, Reed T, Wolf PA, Miller BL, DeCarli C. Midlife cardiovascular risk factors and brain morphology in identical older male twins. Neurology 1999;52:1119-1124.
24. Gouw AA, Van Der Flier WM, Fazekas F, et al. Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: The Leukoaraiosis and Disability Study. Stroke 2008;39:1414-1420.
25. Longstreth WT Jr, Dulberg C, Manolio TA, et al. Incidence, manifestations, and predictors of brain infarcts defined by serial cranial magnetic resonance imaging in the elderly: The Cardiovascular Health Study. Stroke 2002;33:2376-2382.
26. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: An 8-year follow-up of 14 719 initially healthy American women. Circulation 2003;107:391-397.
27. van Dijk EJ, Prins ND, Vermeer SE, et al. C-reactive protein and cerebral small-vessel disease: The Rotterdam Scan Study. Circulation 2005;112:900-905.
28. Wang L, Gill R, Pedersen TL, Higgins LJ, Newman JW, Rutledge JC. Triglyceride-rich lipoprotein lipolysis releases neutral and oxidized FFAs that induce endothelial cell inflammation. J Lipid Res 2009;50:204-213.
29. Wardlaw JM, Smith C, Dichgans M. Mechanisms of sporadic cerebral small vessel disease: Insights from neuroimaging. Lancet Neurol 2013;12:483-497.
30. Schmidt R, Schmidt H, Haybaeck J, et al. Heterogeneity in age-related white matter changes. Acta Neuropathol 2011;122:171-185.
31. Wardlaw JM, Doubal F, Armitage P, et al. Lacunar stroke is associated with diffuse blood-brain barrier dysfunction. Ann Neurol 2009;65:194-202.
32. Fernando MS, Simpson JE, Matthews F, et al. White matter lesions in an unselected cohort of the elderly: molecular pathology suggests origin from chronic hypoperfusion injury. Stroke 2006;37:1391-1398.
33. Gurol ME, Irizarry MC, Smith EE, et al. Plasma betaamyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy. Neurology 2006;66: 23-29.
34. James AP, Pal S, Gennat HC, Vine DF, Mamo JC. The incorporation and metabolism of amyloid-beta into chylomicron-like lipid emulsions. J Alzheimers Dis 2003; 5:179-188.
35. Takechi R, Galloway S, Pallebage-Gamarallage MM, Mamo JC. Chylomicron amyloid-beta in the aetiology of Alzheimer's disease. Atheroscler Suppl 2008;9:19-25.
36. Verghese PB, Castellano JM, Holtzman DM. Apolipoprotein E in Alzheimer's disease and other neurological disorders. Lancet Neurol 2011;10:241-252.
37. Jimenez-Conde J, Biffi A, Rahman R, et al. Hyperlipidemia and reduced white matter hyperintensity volume in patients with ischemic stroke. Stroke 2010;41: 437-442.
38. Longstreth WT Jr, Arnold AM, Beauchamp NJ Jr, et al. Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: The Cardiovascular Health Study. Stroke 2005;36:56-61.
39. ten Dam VH, van den Heuvel DM, van Buchem MA, et al. Effect of pravastatin on cerebral infarcts and white matter lesions. Neurology 2005;64:1807-1809.
40. Debette S, Seshadri S. Vascular risk factors and dementia revisited. J Neurol Neurosurg Psychiatry 2009;80: 1183-1184.